Swedish Scientists Develop Insulin Cells to Reverse Diabetes in Mice
Researchers at Karolinska Institutet and KTH Royal Institute of Technology in Sweden have developed a new method to generate insulin-producing cells from human stem cells. This advancement, published in Stem Cell Reports, has shown promising results in reversing diabetes in mice. The study addresses the challenge of Type 1 diabetes, where the immune system destroys insulin-producing cells in the pancreas, leading to unstable blood sugar levels. The new method produces more mature and uniform insulin cells, which effectively regulate blood sugar when transplanted into diabetic mice. The cells were transplanted into the anterior chamber of the eye, allowing researchers to monitor their development and function over time. This technique demonstrated the cells' ability to mature and maintain blood sugar regulation for several months. 
